Medison Ventures logo

Medison Ventures

Asia, HaMerkaz, Israel, Petah Tiqva

Description

Medison Ventures is the corporate venture arm of Medison.

Investor Profile

Medison Ventures has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (33%)
  • Series A (33%)
  • Series C (33%)

Country Focus

  • Israel (67%)
  • United Kingdom (33%)

Industry Focus

  • Health Care
  • Medical Device
  • Biotechnology
  • Genetics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Medison Ventures frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Shavit Capital
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
GD
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Regah Ventures
North America, New York, United States, New York
Co-Investments: 2
CH
North America, New York, United States, New York
Co-Investments: 1
OurCrowd
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 2
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 1
YG
Asia, Central Region, Singapore, Singapore
Co-Investments: 1

Which angels does Medison Ventures often collaborate with?

RC
Europe, England, United Kingdom, London
Shared Deals: 1
AP
North America, New York, United States, New York
Shared Deals: 2

What are some of recent deals done by Medison Ventures?

Alpha Tau Medical

Tel Aviv, Tel Aviv, Israel

Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT for the treatment of solid cancer tumors.

Health CareMedical Device
Post Ipo EquityMar 8, 2022
Amount Raised: $92,000,000
Alpha Tau Medical

Tel Aviv, Tel Aviv, Israel

Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT for the treatment of solid cancer tumors.

Health CareMedical Device
Series ASep 5, 2018
Amount Raised: $33,705,000
Orchard Therapeutics

London, England, United Kingdom

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CAug 13, 2018
Amount Raised: $150,000,000